Proteomics: In pursuit of effective traumatic brain injury therapeutics

Expert Review of Proteomics

Volumn 12, Issue 1, 2014, Pages 75-82

  Lizhnyak, Pavel N ^a   Ottens, Andrew K ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

brain injury; informatics; inhibitory synapses; post translational modification; proteomics; TBI; temporal; theragnostics; therapeutics

Indexed keywords

ASSAY; HUMAN; NONHUMAN; PHARMACEUTICS; PROTEOMICS; REVIEW; THERAGNOSTIC ASSAY; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN INJURIES; DRUG DEVELOPMENT; DRUG EFFECTS; GENETICS; METABOLISM; PROCEDURES;

BIOLOGICAL MARKER; NEUROPROTECTIVE AGENT; PROTEOME;

ANIMALS; BIOLOGICAL MARKERS; BRAIN INJURIES; DRUG DISCOVERY; HUMANS; NEUROPROTECTIVE AGENTS; PROTEOME; PROTEOMICS;

EID: 84921530674     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.2015.1000869     Document Type: Review

References (68)

1. Faul M, Xu L, Wald MM, Coronado VG. Traumatic brain injury in the united states: Emergency department visits, hospitalizations and deaths 2002-2006 Centers for Disease Control and Prevention, National Center for Injury Prevention and Control 2010
2. Mondello S, Muller U, Jeromin A, et al. Blood-based diagnostics of traumatic brain injuries. Expert Rev Mol Diagn 2011;11(1): 65-78
3. Tsai YT, Wang CC, Leung PO, et al. Extracellular signal-regulated kinase 1/2 is involved in a tamoxifen neuroprotective effect in a lateral fluid percussion injury rat model. J Surg Res 2014;189(1):106-16
4. Zhou XM, Zhou ML, Zhang XS, et al. Resveratrol prevents neuronal apoptosis in an early brain injury model. J Surg Res 2014;189(1):159-65
5. Begum G, Yan HQ, Li L, et al. Docosahexaenoic acid reduces ER stress and abnormal protein accumulation and improves neuronal function following traumatic brain injury. J Neurosci 2014; 34(10):3743-55
6. Mohseni S, Talving P, Wallin G, et al. Preinjury beta-blockade is protective in isolated severe traumatic brain injury. J Trauma Acute Care Surg 2014;76(3):804-8
7. Dachir S, Shabashov D, Trembovler V, et al. Inosine improves functional recovery after experimental traumatic brain injury. Brain Res 2014;1555:78-88
8. Kumar A, Rinwa P, Dhar H. Possible nitric oxide modulation in the protective effects of rutin against experimental head trauma-induced cognitive deficits: behavioral, biochemical, and molecular correlates. J Surg Res 2014;188(1):268-79
9. Talley Watts L, Long JA, Chemello J, et al. Methylene Blue Is Neuroprotective against Mild Traumatic Brain Injury. J Neurotrauma 2014;31(11):1063-71
10. Kabadi SV, Stoica BA, Loane DJ, et al. CR8, a novel inhibitor of CDK, limits microglial activation, astrocytosis, neuronal loss, and neurologic dysfunction after experimental traumatic brain injury. J Cereb Blood Flow Metab 2014;34(3):502-13
11. Rau TF, Kothiwal AS, Rova AR, et al. Administration of low dose methamphetamine 12 h after a severe traumatic brain injury prevents neurological dysfunction and cognitive impairment in rats. Exp Neurol 2014;253:31-40
12. Lopez NE, Lindsay G, Karina LR, et al. Ghrelin decreases motor deficits after traumatic brain injury. J Surg Res 2014; 187(1):230-6
13. McConeghy KW, Hatton J, Hughes L, Cook AM. A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury. CNS Drugs 2012;26(7):613-36
14. Saatman KE, Duhaime AC, Bullock R, et al. Classification of traumatic brain injury for targeted therapies. J Neurotrauma 2008; 25(7):719-38
15. Wagner AK. TBI translational rehabilitation research in the 21st Century: exploring a Rehabilomics research model. Eur J Phys Rehabil Med 2010;46(4):549-56
16. Daoud H, Alharfi I, Alhelali I, et al. Brain injury biomarkers as outcome predictors in pediatric severe traumatic brain injury. Neurocrit Care 2014;20(3):427-35
17. Guingab-Cagmat JD, Cagmat EB, Hayes RL, Anagli J. Integration of proteomics, bioinformatics, and systems biology in traumatic brain injury biomarker discovery. Front Neurol 2013;4(61):1-12
18. Jeter CB, Hergenroeder GW, Hylin MJ, et al. Biomarkers for the diagnosis and prognosis of mild traumatic brain injury/concussion. J Neurotrauma 2013;30(8): 657-70
19. Li BC, Li Y, Xu C, et al. Blast-induced traumatic brain injury of goats in confined space. Neurol Res 2014;36(11):974-82
20. Lin WM, Chen MH, Wang HC, et al. Association between peripheral oxidative stress and white matter damage in acute traumatic brain injury. Biomed Res Int 2014;2014:340936
21. Mondello S, Schmid K, Berger RP, et al. The challenge of mild traumatic brain injury: role of biochemical markers in diagnosis of brain damage. Med Res Rev 2014;34(3):503-31
22. Prieto DA, Ye X, Veenstra TD. Proteomic analysis of traumatic brain injury: the search for biomarkers. Expert Rev Proteomics 2008;5(2):283-91
23. Zetterberg H, Smith DH, Blennow K. Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. Nat Rev Neurol 2013;9(4):201-10
24. Ahmed F, Gyorgy A, Kamnaksh A, et al. Time-dependent changes of protein biomarker levels in the cerebrospinal fluid after blast traumatic brain injury. Electrophoresis 2012;33(24):3705-11
25. Gyorgy AB, Walker J, Wingo D, et al. Reverse phase protein microarray technology in traumatic brain injury. J Neurosci Methods 2010;192(1):96-101
26. Gyorgy A, Ling G, Wingo D, et al. Time-dependent changes in serum biomarker levels after blast traumatic brain injury. J Neurotrauma 2011;28(6):1121-6
27. Kabadi SV, Faden AI. Neuroprotective strategies for traumatic brain injury: improving clinical translation. Int J Mol Sci 2014;15(1):1216-36
28. Xiong Y, Mahmood A, Chopp M. Emerging treatments for traumatic brain injury. Expert Opin Emerg Drugs 2009; 14(1):67-84
29. Maas AI, Roozenbeek B, Manley GT. Clinical trials in traumatic brain injury: past experience and current developments. Neurotherapeutics 2010;7(1):115-26
30. Loane DJ, Faden AI. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci 2010; 31(12):596-604
31. Mehan ND, Strauss KI. Combined ageand trauma-related proteomic changes in rat neocortex: a basis for brain vulnerability. Neurobiol Aging 2012;33(9):1857-73
32. Loov C, Shevchenko G, Geeyarpuram Nadadhur A, et al. Identification of injury specific proteins in a cell culture model of traumatic brain injury. PLoS One 2013;8(2):e55983
33. Ottens AK, Bustamante L, Golden EC, et al. Neuroproteomics: a biochemical means to discriminate the extent and modality of brain injury. J Neurotrauma 2010;27(10):1837-52
34. Cortes DF, Landis MK, Ottens AK. High-capacity peptide-centric platform to decode the proteomic response to brain injury. Electrophoresis 2012;33(24):3712-19
35. Olsen JV, Blagoev B, Gnad F, et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006; 127(3):635-48
36. Maier O, van der Heide T, Johnson R, et al. The function of neurofascin155 in oligodendrocytes is regulated by metalloprotease-mediated cleavage and ectodomain shedding. Exp Cell Res 2006; 312(4):500-11
37. Wu P, Zhao Y, Haidacher SJ, et al. Detection of structural and metabolic changes in traumatically injured hippocampus by quantitative differential proteomics. J Neurotrauma 2013;30(9): 775-88
38. Bales JW, Ma X, Yan HQ, et al. Regional calcineurin subunit B isoform expression in rat hippocampus following a traumatic brain injury. Brain Res 2010;1358:211-20
39. Evans TM, Remmen HV, Purkar A, et al. Microwave and magnetic (M2) proteomics of a mouse model of mild traumatic brain injury. Translational Proteomics 2014;3: 10-21
40. Jaramillo ML, Afar DE, Almazan G, Bell JC. Identification of tyrosine 620 as the major phosphorylation site of myelin-associated glycoprotein and its implication in interacting with signaling molecules. J Biol Chem 1994;269(44): 27240-5
41. Sun C, Zhang L, Chen G. An unexpected role of neuroligin-2 in regulating KCC2 and GABA functional switch. Mol Brain 2013;6(23):1-13
42. Kahle KT, Staley KJ, Nahed BV, et al. Roles of the cation-chloride cotransporters in neurological disease. Nat Clin Pract Neurol 2008;4(9):490-503
43. Bonislawski DP, Schwarzbach EP, Cohen AS. Brain injury impairs dentate gyrus inhibitory efficacy. Neurobiol Dis 2007;25(1):163-9
44. Gackiere F, Vinay L. Serotonergic modulation of post-synaptic inhibition and locomotor alternating pattern in the spinal cord. Front Neural Circuits 2014;8(102):1-7
45. Boulenguez P, Liabeuf S, Bos R, et al. Down-regulation of the potassium-chloride cotransporter KCC2 contributes to spasticity after spinal cord injury. Nat Med 2010; 16(3):302-7
46. Bos R, Sadlaoud K, Boulenguez P, et al. Activation of 5-HT2A receptors upregulates the function of the neuronal K-Cl cotransporter KCC2. Proc Natl Acad Sci USA 2013;110(1):348-53
47. Shen Y, Lindemeyer AK, Gonzalez C, et al. Dihydromyricetin as a novel anti-alcohol intoxication medication. J Neurosci 2012; 32(1):390-401
48. Liang J, Kerstin Lindemeyer A, Shen Y, et al. Dihydromyricetin ameliorates behavioral deficits and reverses neuropathology of transgenic mouse models of Alzheimer's disease. Neurochem Res 2014;39(6):1171-81
49. Liang J, Shen Y, Shao XM, et al. Dihydromyricetin prevents fetal alcohol exposure-induced behavioral and physiological deficits: the roles of GABAA receptors in adolescence. Neurochem Res 2014;39(6):1147-61
50. Gonzalez MI. Brain-derived neurotrophic factor promotes gephyrin protein expression and GABAA receptor clustering in immature cultured hippocampal cells. Neurochem Int 2014;72:14-21
51. Levi S, Le Roux N, Eugene E, Poncer JC. Benzodiazepine ligands rapidly influence GABAA receptor diffusion and clustering at hippocampal inhibitory synapses. Neuropharmacology 2014;88(1):199-208
52. Yu W, Jiang M, Miralles CP, et al. Gephyrin clustering is required for the stability of GABAergic synapses. Mol Cell Neurosci 2007;36(4):484-500
53. Wang E, Gao J, Yang Q, et al. Molecular mechanisms underlying effects of neural stem cells against traumatic axonal injury. J Neurotrauma 2012;29(2):295-312
54. Campos-Martorell M, Salvador N, Monge M, et al. Brain proteomics identifies potential simvastatin targets in acute phase of stroke in a rat embolic model. J Neurochem 2014;130(2):301-12
55. Zgavc T, Hu TT, Van de Plas B, et al. Proteomic analysis of global protein expression changes in the endothelin-1 rat model for cerebral ischemia: rescue effect of mild hypothermia. Neurochem Int 2013; 63(5):379-88
56. Shen S, Loo RR, Wanner IB, Loo JA. Addressing the needs of traumatic brain injury with clinical proteomics. Clin Proteomics 2014;11(1):1-13
57. Brandner S, Thaler C, Buchfelder M, Kleindienst A. Brain-derived protein concentrations in the cerebrospinal fluid: contribution of trauma resulting from ventricular drain insertion. J Neurotrauma 2013;30(13):1205-10
58. Brandner S, Thaler C, Lewczuk P, et al. Neuroprotein dynamics in the cerebrospinal fluid: intraindividual concomitant ventricular and lumbar measurements. Eur Neurol 2013;70(3-4):189-94
59. Manley GT, Diaz-Arrastia R, Brophy M, et al. Common data elements for traumatic brain injury: recommendations from the biospecimens and biomarkers working group. Arch Phys Med Rehabil 2010; 91(11):1667-72
60. Maurer MH. Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF). Mass Spectrom Rev 2010; 29(1):17-28
61. Ottens AK, Stafflinger JE, Griffin HE, et al. Post-acute brain injury urinary signature: a new resource for molecular diagnostics. J Neurotrauma 2014;31(8):782-8
62. Schmid KE, Tortella FC. The diagnosis of traumatic brain injury on the battlefield. Front Neurol 2012;3(90):1-5
63. Rosenfeld JV, McFarlane AC, Bragge P, et al. Blast-related traumatic brain injury. Lancet Neurol 2013;12(9):882-93
64. Boutte AM, Yao C, Kobeissy F, et al. Proteomic analysis and brain-specific systems biology in a rodent model of penetrating ballistic-like brain injury. Electrophoresis 2012;33(24):3693-704
65. Crawford F, Crynen G, Reed J, et al. Identification of plasma biomarkers of TBI outcome using proteomic approaches in an APOE mouse model. J Neurotrauma 2012; 29(2):246-60
66. Siman R, McIntosh TK, Soltesz KM, et al. Proteins released from degenerating neurons are surrogate markers for acute brain damage. Neurobiol Dis 2004;16(2):311-20
67. Siman R, Toraskar N, Dang A, et al. A panel of neuron-enriched proteins as markers for traumatic brain injury in humans. J Neurotrauma 2009;26(11): 1867-77
68. Berger RP, Bazaco MC, Wagner AK, et al. Trajectory analysis of serum biomarker concentrations facilitates outcome prediction after pediatric traumatic and hypoxemic brain injury. Dev Neurosci 2010;32(5-6): 396-405